The Structure of Arylamine N-acetyltransferase from Mycobacterium smegmatis—An Enzyme which Inactivates the Anti-tubercular Drug, Isoniazid
- 1 May 2002
- journal article
- research article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 318 (4) , 1071-1083
- https://doi.org/10.1016/s0022-2836(02)00141-9
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Strategies for New Drug DevelopmentPublished by American Society for Microbiology ,2014
- Eubacterial arylamine N-acetyltransferases – identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residuesMicrobiology, 2001
- An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes.Human Molecular Genetics, 2000
- The genetics and biochemistry of isoniazid resistance inMicrobes and Infection, 2000
- Lessons from the rifamycin biosynthetic gene clusterCurrent Opinion in Chemical Biology, 1999
- Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by IsoniazidScience, 1998
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosisScience, 1998
- The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosisNature, 1992
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960